Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Biocept, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 10 months agobiocept.com
Biocept, Inc., often referred to simply as Biocept, is a prominent molecular diagnostics company based in the US, with its headquarters in San Diego, California. Operating within the pharmaceutical preparation manufacturing industry, Biocept specialises in advanced liquid biopsy solutions for cancer.
The company is renowned for its proprietary Target-Selector™ assays, designed for the highly sensitive and specific detection of circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA). These innovative tests provide critical insights for the diagnosis, prognosis, and monitoring of various cancers, including breast, lung, and melanoma.
Biocept's pioneering work in liquid biopsy empowers oncologists with actionable data, facilitating precision medicine and improved patient outcomes globally. Their advanced technology positions them as a key player in the evolving landscape of cancer detection and treatment guidance.
23
DitchCarbon score
-19 vs industry average
Biocept, Inc.’s score of 23 is lower than 36% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Biocept, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Biocept, Inc. yet.
Biocept, Inc.'s reported carbon emissions
Biocept, Inc., a US-based pharmaceutical preparation manufacturer, does not have publicly available carbon emissions data. The company has not disclosed specific targets for emissions reduction, nor is it a signatory to the Science Based Targets initiative (SBTi) or The Climate Pledge. Without specific emissions reporting, it is not possible to detail their carbon footprint or historical reductions.
Assessing Biocept, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Biocept, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Biocept, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Biocept, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Biocept, Inc.10 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more